Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Minahasa Membangun Hebat Tbk. (HBAT) vs Merck Tbk. (MERK) Price & Performance

Minahasa Membangun Hebat Tbk.Trade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Minahasa Membangun Hebat Tbk. vs Merck Tbk. — how do they compare? Minahasa Membangun Hebat Tbk. trades at Rp222 (market cap 231.04B, 172.5K 24h volume), while Merck Tbk. trades at Rp3,890 (market cap 1.75T, 29.1K 24h volume). The key difference: Merck Tbk. is far larger — about 7.6× Minahasa Membangun Hebat Tbk.'s market cap, and Minahasa Membangun Hebat Tbk. is more actively traded (172.5K versus 29.1K). Which is the better fit depends on your goals.

HBATMERK
Market Cap
231.04B1.75T
Volume
172.5K29.1K
Lot
1.73K291
Turnover
37.62M113.37M
Average Price
218.13,895.98
Value
37.62M113.37M
Indicative Equilibrium Price
2223,890
Indicative Equilibrium Volume
1001

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

HBAT
View details
MERK
View details

About Minahasa Membangun Hebat Tbk.

PT Minahasa Membangun Hebat Tbk was established based on Notarial Deed No. 44 datedJanuary 31, 2020 of Dian Fitriana, S.H., M.Kn., a public notary in Bekasi.

Read more on HBAT

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK